» Articles » PMID: 35045983

Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors

Overview
Journal Cancer Res
Specialty Oncology
Date 2022 Jan 20
PMID 35045983
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor outcome is determined not only by cancer cell-intrinsic features but also by the interaction between cancer cells and their microenvironment. There is great interest in tumor-infiltrating immune cells, yet mast cells have been less studied. Recent work has highlighted the impact of mast cells on the features and aggressiveness of cancer cells, but the eventual effect of mast cell infiltration is still controversial. Here, we review multifaceted findings regarding the role of mast cells in cancer, with a particular focus on breast cancer, which is further complicated because of its classification into subtypes characterized by different biological features, outcome, and therapeutic strategies.

Citing Articles

Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics.

Li J, Jiang Y, Ma M, Wang L, Jing M, Yang Z J Transl Med. 2025; 23(1):135.

PMID: 39885578 PMC: 11783851. DOI: 10.1186/s12967-025-06138-6.


Leaves Extracts Inhibit the Development of Ascitic and Solid Ehrlich Tumors.

Silva L, Cavallini E, da Silva R, SantAna M, Yoshikawa A, Salomao T Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861087 PMC: 11768557. DOI: 10.3390/ph18010024.


Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review.

Panda V, Mishra B, Mahapatra S, Swain B, Malhotra D, Saha S Cancers (Basel). 2025; 17(2).

PMID: 39858015 PMC: 11763662. DOI: 10.3390/cancers17020234.


Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer.

Eren E, Das J, Tollefsbol T Nutrients. 2024; 16(23).

PMID: 39683540 PMC: 11644657. DOI: 10.3390/nu16234143.


Single-cell multiomics reveals simvastatin inhibits pan-cancer epithelial-mesenchymal transition via the MEK/ERK pathway in XBP1+ mast cells.

Lin S, Zhang H, Zhao R, Wu Z, Zhang W, Yu M Sci Rep. 2024; 14(1):29545.

PMID: 39604504 PMC: 11603196. DOI: 10.1038/s41598-024-80858-5.


References
1.
Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A . Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res. 2011; 71(18):5987-97. DOI: 10.1158/0008-5472.CAN-11-1637. View

2.
Aponte-Lopez A, Fuentes-Panana E, Cortes-Munoz D, Munoz-Cruz S . Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer. J Immunol Res. 2018; 2018:2584243. PMC: 5832101. DOI: 10.1155/2018/2584243. View

3.
McKee A, Kirkup B, Madgwick M, Fowler W, Price C, Dreger S . Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth. iScience. 2021; 24(9):103012. PMC: 8426205. DOI: 10.1016/j.isci.2021.103012. View

4.
He L, Zhu Z, Chen S, Wang Y, Gu H . Mammary tumor growth and metastasis are reduced in c-Kit mutant Sash mice. Cancer Med. 2016; 5(6):1292-7. PMC: 4924387. DOI: 10.1002/cam4.696. View

5.
Montemurro F, Di Cosimo S, Arpino G . Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications. Ann Oncol. 2013; 24(11):2715-24. DOI: 10.1093/annonc/mdt287. View